T cell exclusion, immune privilege, and the tumor microenvironment

Science

Volumn 348, Issue 6230, 2015, Pages 74-80

  Joyce, Johanna A ^a   Fearon, Douglas T ^b,c  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b Cold Spring Harbor Laboratory ^*  (United States)

^c WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CXCR4; CHIMERIC ANTIGEN RECEPTOR; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4 ANTIBODY; ENDOTHELIN B RECEPTOR; FAS LIGAND; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; MELANOMA ANTIGEN 1; MONOCYTE CHEMOTACTIC PROTEIN 1; PROGRAMMED DEATH 1 LIGAND 1; PROSTAGLANDIN E2; RANTES; REACTIVE NITROGEN SPECIES; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VASCULOTROPIN;

CANCER; CYTOLOGY; IMMUNE RESPONSE; TUMOR;

CANCER CELL; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CD8+ T LYMPHOCYTE; CELL INTERACTION; COLORECTAL CANCER; CYTOKINE RELEASE; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; DISEASE FREE SURVIVAL; EPSTEIN BARR VIRUS; GLIOBLASTOMA; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE PROLIFERATION; LYMPHOPROLIFERATIVE DISEASE; MONOTHERAPY; NONHUMAN; OVARY CANCER; PANCREAS ADENOCARCINOMA; PHAGOCYTOSIS; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; RECURRENT DISEASE; REVIEW; STROMA CELL; T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR IMMUNOLOGY; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION; ANIMAL; IMMUNOLOGY; IMMUNOTHERAPY; MOUSE; NEOPLASMS; NEOVASCULARIZATION (PATHOLOGY); PROCEDURES; VASCULARIZATION;

ANIMALS; HUMANS; IMMUNE TOLERANCE; IMMUNOTHERAPY; MICE; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; STROMAL CELLS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR MICROENVIRONMENT;

EID: 84928771999     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.aaa6204     Document Type: Review

References (82)

1. D. F. Quail, J. A. Joyce, Nat. Med. 19, 1423-1437 (2013).
2. D. Hanahan, L. M. Coussens, Cancer Cell 21, 309-322 (2012).
3. F. S. Jones, P. Rous, J. Exp. Med. 20, 404-412 (1914).
4. G. Klein, H. O. Sjogren, E. Klein, K. E. Hellstrom, Cancer Res. 20, 1561-1572 (1960).
5. P. B. Medawar, Br. J. Exp. Pathol. 29, 58-69 (1948).
6. P. van der Bruggen et al., Science 254, 1643-1647 (1991).
7. R. D. Schreiber, L. J. Old, M. J. Smyth, Science 331, 1565-1570 (2011).
8. S. A. Rosenberg et al., J. Immunol. 175, 6169-6176 (2005).
9. S. A. Rosenberg, N. P. Restifo, Science 348, 62-68 (2015).
10. S. A. Rosenberg et al., Clin. Cancer Res. 17, 4550-4557 (2011).
11. S. R. Riddell et al., Science 257, 238-241 (1992).
12. E. B. Papadopoulos et al., N. Engl. J. Med. 330, 1185-1191 (1994).
13. F. S. Hodi et al., N. Engl. J. Med. 363, 711-723 (2010).
14. J. R. Brahmer et al., N. Engl. J. Med. 366, 2455-2465 (2012).
15. S. L. Topalian et al., N. Engl. J. Med. 366, 2443-2454 (2012).
16. T. Powles et al., Nature 515, 558-562 (2014).
17. R. S. Herbst et al., Nature 515, 563-567 (2014).
18. P. C. Tumeh et al., Nature 515, 568-571 (2014).
19. P. Sharma, J. P. Allison, Science 348, 56-61 (2015).
20. T. R. Simpson et al., J. Exp. Med. 210, 1695-1710 (2013).
21. S. Z. Josefowicz, L. F. Lu, A. Y. Rudensky, Annu. Rev. Immunol. 30, 531-564 (2012).
22. T. Okazaki, S. Chikuma, Y. Iwai, S. Fagarasan, T. Honjo, Nat. Immunol. 14, 1212-1218 (2013).
23. F. Wei et al., Proc. Natl. Acad. Sci. U.S.A. 110, E2480-E2489 (2013).
24. R. E. Royal et al., J. Immunother. 33, 828-833 (2010).
25. Y. Naito et al., Cancer Res. 58, 3491-3494 (1998).
26. J. Galon et al., Science 313, 1960-1964 (2006).
27. L. Zhang et al., N. Engl. J. Med. 348, 203-213 (2003).
28. E. Sato et al., Proc. Natl. Acad. Sci. U.S.A. 102, 18538-18543 (2005).
29. C. Feig et al., Proc. Natl. Acad. Sci. U.S.A. 110, 20212-20217 (2013).
30. A. M. Lesokhin et al., Cancer Res. 72, 876-886 (2012).
31. L. J. Bayne et al., Cancer Cell 21, 822-835 (2012).
32. Y. Pylayeva-Gupta, K. E. Lee, C. H. Hajdu, G. Miller, D. Bar-Sagi, Cancer Cell 21, 836-847 (2012).
33. D. C. Strachan et al., OncoImmunology 2, e26968 (2013).
34. Y. Zhu et al., Cancer Res. 74, 5057-5069 (2014).
35. A. J. Garcia et al., Mol. Cell. Biol. 34, 2017-2028 (2014).
36. D. G. DeNardo et al., Cancer Discov. 1, 54-67 (2011).
37. B. Molon et al., J. Exp. Med. 208, 1949-1962 (2011).
38. G. T. Motz et al., Nat. Med. 20, 607-615 (2014).
39. X. Zang et al., Mod. Pathol. 23, 1104-1112 (2010).
40. R. J. Buckanovich et al., Nat. Med. 14, 28-36 (2008).
41. Y. Huang, S. Goel, D. G. Duda, D. Fukumura, R. K. Jain, Cancer Res. 73, 2943-2948 (2013).
42. G. C. Jayson, D. J. Hicklin, L. M. Ellis, Nat. Rev. Clin. Oncol. 9, 297-303 (2012).
43. R. K. Shrimali et al., Cancer Res. 70, 6171-6180 (2010).
44. Y. Huang et al., Proc. Natl. Acad. Sci. U.S.A. 109, 17561-17566 (2012).
45. D. I. Gabrilovich et al., Nat. Med. 2, 1096-1103 (1996).
46. J. Hamzah et al., Nature 453, 410-414 (2008).
47. A. Johansson, J. Hamzah, C. J. Payne, R. Ganss, Proc. Natl. Acad. Sci. U.S.A. 109, 7841-7846 (2012).
48. A. Calcinotto et al., J. Immunol. 188, 2687-2694 (2012).
49. E. D. Thompson, H. L. Enriquez, Y. X. Fu, V. H. Engelhard, J. Exp. Med. 207, 1791-1804 (2010).
50. Y. Ma et al., Cancer Res. 74, 436-445 (2014).
51. M. L. Broz et al., Cancer Cell 26, 638-652 (2014).
52. K. Hildner et al., Science 322, 1097-1100 (2008).
53. B. Ruffell et al., Cancer Cell 26, 623-637 (2014).
54. X. Yang et al., Cancer Cell 25, 37-48 (2014).
55. M. Z. Noman et al., J. Exp. Med. 211, 781-790 (2014).
56. O. R. Colegio et al., Nature 513, 559-563 (2014).
57. M. J. Cavnar et al., J. Exp. Med. 210, 2873-2886 (2013).
58. P. J. Murray et al., Immunity 41, 14-20 (2014).
59. B. Z. Qian, J. W. Pollard, Cell 141, 39-51 (2010).
60. D. H. Munn, A. L. Mellor, Trends Immunol. 34, 137-143 (2013).
61. M. Platten, W. Wick, B. J. Van den Eynde, Cancer Res. 72, 5435-5440 (2012).
62. C. Smith et al., Cancer Discov. 2, 722-735 (2012).
63. R. B. Holmgaard, D. Zamarin, D. H. Munn, J. D. Wolchok, J. P. Allison, J. Exp. Med. 210, 1389-1402 (2013).
64. M. D. Sharma et al., Immunity 38, 998-1012 (2013).
65. P. Zhou et al., Nature 506, 52-57 (2014).
66. S. M. Pyonteck et al., Nat. Med. 19, 1264-1272 (2013).
67. G. L. Beatty et al., Science 331, 1612-1616 (2011).
68. N. I. Affara et al., Cancer Cell 25, 809-821 (2014).
69. A. Pommier et al., Proc. Natl. Acad. Sci. U.S.A. 110, 13085-13090 (2013).
70. Y. Murata, T. Kotani, H. Ohnishi, T. Matozaki, J. Biochem. 155, 335-344 (2014).
71. K. Weiskopf et al., Science 341, 88-91 (2013).
72. H. Salmon et al., J. Clin. Invest. 122, 899-910 (2012).
73. M. Kraman et al., Science 330, 827-830 (2010).
74. E. W. Roberts et al., J. Exp. Med. 210, 1137-1151 (2013).
75. M. H. Sherman et al., Cell 159, 80-93 (2014).
76. C. J. Scotton et al., Cancer Res. 62, 5930-5938 (2002).
77. J. J. Liang et al., Cancer Epidemiol. Biomarkers Prev. 19, 2598-2604 (2010).
78. Y. Akishima-Fukasawa et al., Am. J. Clin. Pathol. 132, 202-210, quiz 307 (2009).
79. M. C. Poznansky et al., Nat. Med. 6, 543-548 (2000).
80. J. Eyles et al., J. Clin. Invest. 120, 2030-2039 (2010).
81. J. Predina et al., Proc. Natl. Acad. Sci. U.S.A. 110, E415-E424 (2013).
82. T. Chiba et al., Br. J. Cancer 91, 1711-1717 (2004).